BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 105.00
-3.00 (-2.78%)
At close: Jul 31, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 2.27 billion as of July 31, 2026. Its market cap has decreased by -50.47% in one year.
Market Cap
2.27B
Enterprise Value
n/a
Revenue
1.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
105.00
ChartMarket Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 2.27B, a decrease of -96.02%. That is a compound annual growth rate of -41.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.27B | -61.82% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 97.33B |
| Corentec | 52.42B |
| DENTIS CO.,Ltd | 39.21B |
| Genolution | 23.41B |
| Finemedix | 22.97B |
| Sanigen Co. | 13.29B |
| TASCOM | 11.43B |
| Alpha AI | 10.45B |